Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulation of (e)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4-methoxybenzylsulphone with enhanced stability and bioavailability

Formulation of (e)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4-methoxybenzylsulphone with enhanced stability and bioavailability

US Patent 12156856 · Granted Dec 3, 2024

Estimated economic value: $285,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical formulation of arsenic trioxide2023
Formulation of (E)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4-methoxybenz2022
Formulations for the treatment of pain2020
Methods and compositions for treatment of cancer2020
Formulations with enhanced stability and bioavailability for administration of (2018
Stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfone2017
Stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfone2015
Compositions and methods for prevention and treatment of wounds2015
Formulations for the treatment of pain2014
Formulations for parenteral administration of amino-substituted (E)-2, 6-dialkox2013
Formulations for parenteral administration of (e)-2, 6-dialkoxystyryl 4-substitu2011
Biodegradable polymer blends for drug delivery1999